---
title: "Perma-Fix (PESI) Receives a Buy from Craig-Hallum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285505831.md"
description: "In a recent report, Craig-Hallum analyst Aaron Spychalla maintained a Buy rating on Perma-Fix (PESI), with shares closing at $11.78. Spychalla, a 5-star analyst with a 63.52% success rate, focuses on the Industrials sector. The consensus rating for Perma-Fix is a Moderate Buy."
datetime: "2026-05-07T07:46:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285505831.md)
  - [en](https://longbridge.com/en/news/285505831.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285505831.md)
---

# Perma-Fix (PESI) Receives a Buy from Craig-Hallum

In a report released yesterday, Aaron Spychalla from Craig-Hallum maintained a Buy rating on Perma-Fix. The company’s shares closed yesterday at $11.78.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Spychalla is a 5-star analyst with an average return of 24.7% and a 63.52% success rate. Spychalla covers the Industrials sector, focusing on stocks such as Thermon Group Holdings, Orion Group Holdings, and Babcock & Wilcox Company.

The analyst consensus on Perma-Fix is currently a Moderate Buy rating.

### Related Stocks

- [PESI.US](https://longbridge.com/en/quote/PESI.US.md)
- [THR.US](https://longbridge.com/en/quote/THR.US.md)
- [ORN.US](https://longbridge.com/en/quote/ORN.US.md)
- [BW.US](https://longbridge.com/en/quote/BW.US.md)
- [BWSN.US](https://longbridge.com/en/quote/BWSN.US.md)
- [BWNB.US](https://longbridge.com/en/quote/BWNB.US.md)
- [BW-A.US](https://longbridge.com/en/quote/BW-A.US.md)

## Related News & Research

- [Perma-Fix Environmental Services Prices $8.75 Offering; Over-Allotment Taken, Netting ~$21.1M](https://longbridge.com/en/news/286752989.md)
- [Perma-Fix Environmental Services (PESI) to Release Earnings on Thursday](https://longbridge.com/en/news/284714332.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)
- [Rare S&P 500 Signals: What History Says About This Rally](https://longbridge.com/en/news/286600805.md)